1,474
Views
18
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA SOX21-AS1 modulates lung cancer progress upon microRNA miR-24-3p/PIM2 axis

, , , , &
Pages 6724-6737 | Received 18 May 2021, Accepted 10 Jul 2021, Published online: 13 Sep 2021

References

  • Chen W, Zheng R, Zhang S, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.
  • Nasim F, Sabath BF, Eapen GA. Lung Cancer. Med Clin North Am. 2019;103(3):463–473.
  • Cao M, Chen W. Epidemiology of lung cancer in China. Thorac Cancer. 2019;10(1):3–7.
  • Hensing T, et al. A personalized treatment for lung cancer: molecular pathways, targeted therapies, and genomic characterization. Adv Exp Med Biol. 2014;799:85–117.
  • Peng W, Wang J, Shan B, et al. Diagnostic and prognostic potential of circulating long non-Coding RNAs in non small cell lung cancer. Cell Physiol Biochem. 2018;49(2):816–827. .
  • Huang Q, Wei H, Wu Z, et al. Preferentially expressed antigen of melanoma prevents lung cancer metastasis. PLoS One. 2016;11(7):e0149640. .
  • Wu B, et al. [Comparison of the survival time in the non-small cell lung cancer patients with different organ metastasis]. Zhongguo Fei Ai Za Zhi. 2019;22(2):105–110.
  • Song Z, Liu Y. [Progress of liquid biopsy in early diagnosis of lung cancer]. Zhongguo Fei Ai Za Zhi. 2018;21(8):620–627.
  • Wang J, Su Z, Lu S, et al. LncRNA HOXA-AS2 and its molecular mechanisms in human cancer. Clin Chim Acta. 2018;485:229–233.
  • Li J, Li Z, Zheng W, et al. LncRNA-ATB: an indispensable cancer-related long noncoding RNA. Cell Prolif. 2017;50(6):e12381. .
  • Charles Richard JL, Eichhorn PJA. Platforms for Investigating LncRNA Functions. SLAS Technol. 2018;23(6):493–506.
  • Wei GH, Wang X. lncRNA MEG3 inhibit proliferation and metastasis of gastric cancer via p53 signaling pathway. Eur Rev Med Pharmacol Sci. 2017;21(17):3850–3856.
  • Deng SJ, Chen H-Y, Ye Z, et al. Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription. Oncogene. 2018;37(44):5811–5828. .
  • Zheng L, Xiang C, Li X, et al. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling. J Hematol Oncol. 2018;11(1):72. .
  • Yang CM, Wang T-H, Chen H-C, et al. Aberrant DNA hypermethylation-silenced SOX21-AS1 gene expression and its clinical importance in oral cancer. Clin Epigenetics. 2016;8(1):129. .
  • Wei AW, Li LF. Long non-coding RNA SOX21-AS1 sponges miR-145 to promote the tumorigenesis of colorectal cancer by targeting MYO6. Biomed Pharmacother. 2017;96:953–959.
  • Wei C, Wang H, Xu F, et al. LncRNA SOX21-AS1 is associated with progression of hepatocellular carcinoma and predicts prognosis through epigenetically silencing p21. Biomed Pharmacother. 2018;104:137–144.
  • Lu X, Huang C, He X, et al. A novel long Non-Coding RNA, SOX21-AS1, indicates a poor prognosis and promotes lung adenocarcinoma proliferation. Cell Physiol Biochem. 2017;42(5):1857–1869. .
  • Xu Y, Wu H, Wu L, et al. Silencing of long non-coding RNA SOX21-AS1 inhibits lung adenocarcinoma invasion and migration by impairing TSPAN8 via transcription factor GATA6. Int J Biol Macromol. 2020;164:1294–1303.
  • Fabris L, Ceder Y, Chinnaiyan AM, et al. The potential of microRNAs as prostate cancer biomarkers. Eur Urol. 2016;70(2):312–322. .
  • Han X, Li Q, Liu C, et al. Overexpression miR-24-3p repressed Bim expression to confer tamoxifen resistance in breast cancer. J Cell Biochem. 2019;120(8):12966–12976.
  • Yin Y, Zhong J, Li S-W, et al. TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer. Oncotarget. 2016;7(52):86755–86765. .
  • Jing P, Zhao N, Xie N, et al. miR-24-3p/FGFR3 signaling as a novel axis is involved in Epithelial-Mesenchymal transition and regulates lung adenocarcinoma progression. J Immunol Res. 2018;2018:2834109.
  • Kronschnabl P, et al. Inhibition of PIM2 in liver cancer decreases tumor cell proliferation in vitro and in vivo primarily through the modulation of cell cycle progression. Int J Oncol. 2020;56(2):448–459.
  • Uddin N, Kim R-K, Yoo K-C, et al. Persistent activation of STAT3 by PIM2-driven positive feedback loop for epithelial-mesenchymal transition in breast cancer. Cancer Sci. 2015;106(6):718–725. .
  • Niba ETE, Rochmah MA, Harahap NIF, et al. Spinal muscular atrophy: advanced version of screening system with Real-Time mCOP-PCR and PCR-RFLP for SMN1 deletion. Kobe J Med Sci. 2019;65(2):E49–E53.
  • Lei KF, Kao CH, Tsang NM. High throughput and automatic colony formation assay based on impedance measurement technique. Anal Bioanal Chem. 2017;409(12):3271–3277.
  • He X, Dai J, Fan Y, et al. Regulation function of MMP-1 downregulated by siRNA on migration of heat-denatured dermal fibroblasts. Bioengineered. 2017;8(6):686–692.
  • Omar Zaki SS, Kanesan L, Leong MYD, et al. The influence of serum-supplemented culture media in a transwell migration assay. Cell Biol Int. 2019;43(10):1201–1204.
  • Marshall J. Transwell(®) invasion assays. Methods Mol Biol. 2011;769:97–110.
  • Yao J, Gao RY, Luo MH, et al. Possible role of microRNA miRNA-IL-25 interaction in mice with ulcerative colitis. Bioengineered. 2020;11(1):862–871. .
  • Lee NP, Chan CM, Tung LN, et al. Tumor xenograft animal models for esophageal squamous cell carcinoma. J Biomed Sci. 2018;25(1):66.
  • Zhang N, Liu JF. MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN. Bioengineered. 2020;11(1):972–983.
  • Zhang X, Zhao X, Li Y, et al. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1. J Cell Physiol. 2019;234(10):17494–17504. .
  • Liu X, Song J, Kang Y, et al. Long noncoding RNA SOX21-AS1 regulates the progression of triple-negative breast cancer through regulation of miR-520a-5p/ORMDL3 axis. J Cell Biochem. 2020;121(11):4601–4611. .
  • Gai SY, Yuan ZH. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells. Neoplasma. 2020;67(2):333–343.
  • Li X, Han X, Wei P, et al. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther. 2020;21(5):452–462. .
  • Huang W, Gu J, Tao T, et al. MiR-24-3p inhibits the progression of pancreatic ductal adenocarcinoma through LAMB3 downregulation. Front Oncol. 2019;9:1499.
  • Tang X, Cao T, Zhu Y, et al. PIM2 promotes hepatocellular carcinoma tumorigenesis and progression through activating NF-κB signaling pathway. Cell Death Dis. 2020;11(7):510. .
  • Ren C, Yang T, Qiao P, et al. PIM2 interacts with tristetraprolin and promotes breast cancer tumorigenesis. Mol Oncol. 2018;12(5):690–704. .